MONASH University is a partner in three of 16 research teams that were given $118m from the National Health and Medical Research Council (NHMRC).
The university will share in $22.23m of the grants and will use the funds for research into cures and treatments for conditions such as stroke, Parkinson’s disease, cancer and diabetes.
Monash Medical Centre received $8.25m as part of the grants to identify new drugs for treating brain diseases and improve recovery.
Prince Henry’s Institute of Medical Research, which is affiliated with the university’s medical faculty, received $7.4m to study the role of hormones in infertility and diseases of the reproductive organs.
A team of researchers from the university and the Peter MacCallum Cancer Institute also received $6.55m for research into the immune system’s role in human disease.
Monash University vice-chancellor Peter Darvall said: “Monash and its affiliate institutes of medical research have performed extremely well in this round of NHMRC program grants.
“We congratulate our researchers on their achievements.”
Head of Monash’s department of pharmacology Bevyn Jarrott said the Monash Medical Centre grant would help his team tackle important neurological diseases.
“This will allow us to find drugs that might treat these diseases in a rational, rather than haphazard, way.”
